SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma.
Saved in:
| Title: | SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Chung JH; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, South Korea., Jung HR; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, South Korea., Jung AR; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, South Korea., Lee YC; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, South Korea., Kong M; Department of Radiation Oncology, School of Medicine, Kyung Hee University, Seoul, South Korea., Lee JS; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Eun YG; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, South Korea. ygeun@khu.ac.kr. |
| Source: | Scientific reports [Sci Rep] 2018 Jan 26; Vol. 8 (1), pp. 1677. Date of Electronic Publication: 2018 Jan 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
